Inventor

MOURITSEN SOEREN

DK7 patents

⚠️ This page may combine multiple inventors who share the name “MOURITSEN SOEREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PHARMEXA AS

3 patents

US7005498B1Feb 28, 2006

Methods for therapeutic vaccination

PHARMEXA AS50 citations92

US7070784B1Jul 4, 2006

Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues

PHARMEXA AS29 citations90

US7118750B1Oct 10, 2006

Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA

PHARMEXA AS4 citations58

BN IMMUNOTHERAPEUTICS INC

2 patents

US7807441B2Oct 5, 2010

Methods for therapeutic vaccination

BN IMMUNOTHERAPEUTICS INC11 citations80

US7820633B2Oct 26, 2010

Methods for therapeutic vaccination

BN IMMUNOTHERAPEUTICS INC0 citations46

MOURITSEN & ELSNER AS

1 patent

US6262256B1Jul 17, 2001

Article for tuesyl-activated dextran for solid-phase coupling

MOURITSEN & ELSNER AS3 citations54

MOURITSEN & ELSNER A S

1 patent

US5874569AFeb 23, 1999

Method of preparing tresyl-activated dextran, article having tresyl-activated dextran fixed covalently to its surface, and immobilization of chemical compounds thereto

MOURITSEN & ELSNER A S4 citations54